HDL therapy for the acute treatment of atherosclerosis (Q35062398)

6 August 2017

1 reference

title

HDL therapy for the acute treatment of atherosclerosis (English)

1 reference

6 August 2017

1 reference

Roger S Newton

1

1 reference

6 August 2017

Brian R Krause

series ordinal

2

1 reference

6 August 2017

publication date

1 December 2002

1 reference

Atherosclerosis. Supplements

6 August 2017

published in

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

31-38

1 reference

Artificial HDL as an anti-atherosclerotic drug

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Reassembly in vitro of a serum high-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Regulation of cellular sterol flux and synthesis by human serum lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Apolipoprotein A-I and A-II kinetic parameters as assessed by endogenous labeling with [(2)H(3)]leucine in middle-aged and elderly men and women

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Physical and chemical characteristics of apolipoprotein A-I-lipid complexes produced by Chinese hamster ovary cells transfected with the human apolipoprotein A-I gene

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Transgenic Rabbits Expressing Human Apolipoprotein A-I in the Liver

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Inhibition of Atherosclerosis Development in Cholesterol-Fed Human Apolipoprotein A-I–Transgenic Rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Adenovirus-mediated transfer of a gene encoding human apolipoprotein A-I into normal mice increases circulating high-density lipoprotein cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Effects of Adenovirus-Mediated Human Apo A-I Gene Transfer on Neointima Formation After Endothelial Denudation in Apo E–Deficient Mice

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Effect of promoters and enhancers on expression, transgene DNA persistence, and hepatotoxicity after adenoviral gene transfer of human apolipoprotein A-I

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Intravenous Injection of Rabbit Apolipoprotein A-I Inhibits the Progression of Atherosclerosis in Cholesterol-Fed Rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Effect of up-regulating individual steps in the reverse cholesterol transport pathway on reverse cholesterol transport in normolipidemic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Increased cholesterol efflux potential of sera from ApoA-IMilano carriers and transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Recombinant apolipoprotein A-IMilano dimer inhibits carotid intimal thickening induced by perivascular manipulation in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Effects of Recombinant Apolipoprotein A-I Milano on Aortic Atherosclerosis in Apolipoprotein E–Deficient Mice

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Recombinant apolipoprotein A-I(Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Synthetic peptide analogs of apolipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Design of a new class of amphipathic helical peptides for the plasma apolipoproteins that promote cellular cholesterol efflux but do not activate LCAT.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Structural studies of a peptide activator of human lecithin-cholesterol acyltransferase.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Structural and metabolic consequences of liposome-lipoprotein interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Remodeling and shuttling. Mechanisms for the synergistic effects between different acceptor particles in the mobilization of cellular cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

The influence of size and composition on the cholesterol mobilizing properties of liposomes in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Rapid restoration of normal endothelial functions in genetically hyperlipidemic mice by a synthetic mediator of reverse lipid transport

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Effects of intravenous infusion of lipid-free apo A-I in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Acute effects of intravenous infusion of ApoA1/phosphatidylcholine discs on plasma lipoproteins in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Efflux of cholesterol from cholesterol loaded macrophages by incubation with synthetic HDL-particles

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

A novel liver X receptor agonist establishes species differences in the regulation of cholesterol 7alpha-hydroxylase (CYP7a).

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

High-density lipoprotein restores endothelial function in hypercholesterolemic men.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Intravenously administered lecithin liposomes: a synthetic antiatherogenic lipid particle

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Large versus small unilamellar vesicles mediate reverse cholesterol transport in vivo into two distinct hepatic metabolic pools. Implications for the treatment of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900044-2

7 January 2021

10.1016/S1567-5688(02)00044-2

Identifiers

DOI

1 reference

6 August 2017

1 reference